[Indications and Clinical use]: For thermal power and body fluid supplement.
[Strength]: 500ml: 25g Glucose and 4.5g Sodium Chloride
250ml: 12.5g Glucose and 2.25g Sodium Chloride
100ml: 5g Glucose and 0.9g Sodium Chloride
Product Name: Glucose and Sodium Chloride Injection,
Product Description: A clear, colourless liquid.
Strength: (1)500ml: Glucose: 25g/Sodium Chloride: 4.5g;
(2)250ml: Glucose: 12.5g/Sodium Chloride: 2.25g;
(3)100ml: Glucose: 5g/Sodium Chloride: 0.9g
INN or Generic Name: Dextrose and Sodium Chloride Injection
Pharmaceutical Dosage Form: injection
Packaging: butyl rubber stopper and aluminium cap; polypropylene bottle; Glass bottle
(1)500ml: 30PCS/CTN, 713 CTNS/20'FT, 1532CTNS /40'FT, 1796CTNS /40'HQ
(2)250ml: 30PCS/CTN, 1082 CTNS/20'FT, 2324 CTNS /40'FT, 2725 CTNS /40'HQ
(3)100ml: 80PCS/CTN, 726 CTNS/20'FT, 1559 CTNS/40'FT, 1828 CTNS/40'HQ
Port: Any port (depends on requests) Certificate: GMP
Exporting Region: Areas which GMP is applicable
Intravenous solutions containing Dextrose and Sodium Chloride are indicated for parenteral replenishment of fluid, minimal carbohydrate calories, and sodium chloride as required by the clinical condition of the patients.
Posology and method of administration
The dose is dependent upon the age, weight and clinical condition of the patient.
As reported in the literature, the dosage and constant infusion rate of intravenous dextrose must be selected with caution in pediatric patients, particularly neonates and low birth weight infants, because of the increased risk of hyperglycemia/hypoglycemia.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. See PRECAUTIONS.
Additives may be incompatible. Consult with pharmacist, if available. When introducing additives, use aseptic technique, mix thoroughly and do not store.
Solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products.
Special warning and precautions for use:
Solutions containing sodium ions should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency and in clinical states in which there exists edema with sodium retention.
Excessive administration of potassium-free solutions may result in significant hypokalemia.
In patients with diminished renal function, administration of solutions containing sodium ions may result in sodium retention.
The intravenous administration of these solutions can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema.
The risk of dilutional states is inversely proportional to the electrolyte concentrations of administered parenteral solutions. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of such solutions.
Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.
Solutions containing dextrose should be used with caution in patients with known subclinical or overt diabetes mellitus.
Caution must be exercised in the administration of parenteral fluids, especially those containing sodium ions to patients receiving corticosteroids or corticotropin.
Do not administer unless solution is clear and container is undamaged. Discard unused portion.
Interaction with other medicinal products and other forms of interactions none known
Pregnancy and lactation
Pregnancy category C:
Animal reproduction studies have not been conducted with dextrose or sodium chloride. It is also not known whether dextrose or sodium chloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Dextrose or sodium chloride should be given to a pregnant woman only if clearly needed.
The safety and effectiveness in the pediatric population are based on the similarity of the clinical conditions of the pediatric and adult populations. In neonates or very small infants, the volume of fluid may affect fluid and electrolyte balance.
Frequent monitoring of serum glucose concentrations is required when dextrose is prescribed to pediatric patients, particularly neonates and low birth weight infants.
In very low birth weight infants, excessive or rapid administration of dextrose injection may result in increased serum osmolality and possible intracerebral hemorrhage.
An evaluation of current literature revealed no clinical experience identifying differences in response between elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Sodium ions are known to be substantially excreted by the kidney, and the risk of toxic reactions may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.
Effects on ability to drive and use machine
Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia.
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.
Overdose and special antidotes
In the event of overhydration or solute overload, re-evaluate the patient and institute appropriate corrective measures. Please see WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS.
When administered intravenously, these solutions provide a source of water, carbohydrate and electrolytes.
Solutions which provide combinations of hypotonic or isotonic concentrations of dextrose and of sodium chloride are suitable for parenteral maintenance or replacement of water and electrolyte requirements with minimal carbohydrate calories.
Solutions containing carbohydrate in the form of dextrose restore blood glucose levels and provide calories. Carbohydrate in the form of dextrose may aid in minimizing liver glycogen depletion and exerts a protein-sparing action. Dextrose injected parenterally undergoes oxidation to carbon dioxide and water.
Sodium chloride in water dissociates to provide sodium (Na+) and chloride (Cl¯) ions. Sodium (Na+) is the principal cation of the extracellular fluid and plays a large part in the therapy of fluid and electrolyte disturbances. Chloride (Cl¯) has an integral role in buffering action when oxygen and carbon dioxide exchange occurs in the red blood cells. The distribution and excretion of sodium (Na+) and chloride (Cl¯) are largely under the control of the kidney which maintains a balance between intake and output.
Water is an essential constituent of all body tissues and accounts for approximately 70% of total body weight. Average normal adult daily requirements range from two to three liters (1.0 to 1.5 liters each for insensible water loss by perspiration and urine production). Water balance is maintained by various regulatory mechanisms. Water distribution depends primarily on the concentration of electrolytes in the body compartments and sodium (Na+) plays a major role in maintaining physiologic equilibrium.
Dextrose is rapidly absorbed from the gastrointestinal tract. Peak plasma concentrations of dextrose occur about 40 minutes after oral doses in hypoglycaemic patients. It is metabolised via pyruvic or lactic acid to carbon dioxide and water with the release of energy. All body cells are capable of oxidising dextrose and it forms the principal source of energy in cellular metabolism.
Sodium chloride is well absorbed from the gastrointestinal tract. Excess sodium is mainly excreted by the kidney, and small amounts are lost in the faeces and sweat.
[ Return ]